Without domestic standards, Indian manufacturers have been relying on internal protocols or foreign manuals to manufacture weight-loss drugs, a market that CareEdge expects to cross $347 million in India sales by 2035.
Without domestic standards, Indian manufacturers have been relying on internal protocols or foreign manuals to manufacture weight-loss drugs, a market that CareEdge expects to cross $347 million in India sales by 2035.
Share this Article
Recommended